The compound enters your bloodstream and distributes throughout your body, affecting all tissues including your brain
Disclosures: Alex Chang: Nothing to Disclose, Ethan Berman: Nothing to Disclose, Maham Ghani: Nothing to Disclose, Alexa Giammarino: Nothing to Disclose, Nishi Joshi: Nothing to Disclose, Nazia Qazi: Nothing to Disclose, Jennifer Onwochei: Nothing to Disclose, James Park: Nothing to Disclose, Nabil Dagher: Nothing to Disclose, Sanjaya Satapathy: Gilead Sciences: Grant/Research Support, Durect Pharma: Grant/Research Support, Fibronostics: Grant/Research Support, Novartis: Grant/Research Support, Zydus Pharma: Grant/Research Support, Boehringer Ingelheim: Grant/Research Support, Intercept Pharma: Grant/Research Support 1556 TRENDS IN POST-DISCHARGE PHARMACOLOGICAL ALCOHOL CESSATION THERAPY AND PSYCHIATRIC REFERRALS FOR HOSPITALIZED PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE (ALD) BETWEEN 2014 TO 2023: A NATIONWIDE STUDY Emily Shu-Yen Chan 1 Yee Hui Yeo 2 Sikai Qiu 3 Hyunseok Kim 2 Peng-Sheng Ting 4 , 1 Department of Internal Medicine, Weiss Memorial Hospital, Chicago, IL, 2 Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, LA, 3 Department of clinical medicine, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 4 Tulane University School of Medicine Background: Alcohol- associated liver disease (ALD) is associated with high rates of alcohol relapse and unfortunately many patients do not follow up after discharge for alcohol cessation therapy
AMNA NAWAZ: I mean, you did play a key role in brokering that 2022 peace deal
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
